Thomas Schlumpberger

No open positions remaining

Health Technology

Consumer Services

Profile

Thomas Schlumpberger worked as the Chief Executive Officer at Pictor Ltd. from 2020 to 2022, and as the Chief Executive Officer & Director at Nanomix Corp.
from 2022 to 2023.
Prior to that, he was the Executive Vice President-Diagnostics at Anixa Biosciences, Inc. in 2019.
He also worked as the Vice President-Diagnostics at Singulex, Inc. and as the Vice President-Business Development at Inivata, Inc. from 2018 to 2019.
Dr. Schlumpberger holds a doctorate degree from the University of California, Berkeley and a graduate degree from Technische Universität München.

Former positions of Thomas Schlumpberger

Companies	Position	End
NANOMIX CORPORATION	Chief Executive Officer	2023-11-01
Pictor Ltd. Pictor Ltd. BiotechnologyHealth Technology Develops a technology for multiplexed testing for blood and other biological fluids	Chief Executive Officer	2021-12-31
ANIXA BIOSCIENCES, INC.	Corporate Officer/Principal	2020-06-30
Inivata, Inc. Inivata, Inc. Part of NeoGenomics, Inc., Inivata, Inc. is a cancer diagnostic, pharmaceutical services, and information service company. The company is based in Jefferson City, MO. NeoGenomics Laboratories has been providing laboratory diagnostics and clinical trial services for over 18 years. The company works in partnership with cancer care teams to provide vital oncology answers that transform the lives of people living with cancer. NeoGenomics offers a comprehensive menu of diagnostic services, ranging from traditional to state-of-the-art testing, to support a personalized test approach. The company is committed to improving patient care through communication, accuracy, reliability, and efficiency. NeoGenomics serves oncologists, pathologists, pharmaceutical companies, and academic centers in their pursuit of providing better futures for people living with cancer.	Corporate Officer/Principal	2019-07-31
Singulex, Inc. Singulex, Inc. Medical SpecialtiesHealth Technology Operates as an immunodiagnostics company	Corporate Officer/Principal	-

See the detail of Thomas Schlumpberger's experience

Training of Thomas Schlumpberger

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Thomas Schlumpberger's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Anixa Biosciences, Inc. Anixa Biosciences, Inc. BiotechnologyHealth Technology Develops therapies and vaccines for oncology and infectious disease	Health Technology
Singulex, Inc. Singulex, Inc. Medical SpecialtiesHealth Technology Operates as an immunodiagnostics company	Health Technology
University of California, Berkeley University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Technische Universität München Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Pictor Ltd. Pictor Ltd. BiotechnologyHealth Technology Develops a technology for multiplexed testing for blood and other biological fluids	Health Technology
Nanomix Corp. Nanomix Corp. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes point-of-care diagnostic tests	Health Technology
Inivata, Inc. Inivata, Inc. Part of NeoGenomics, Inc., Inivata, Inc. is a cancer diagnostic, pharmaceutical services, and information service company. The company is based in Jefferson City, MO. NeoGenomics Laboratories has been providing laboratory diagnostics and clinical trial services for over 18 years. The company works in partnership with cancer care teams to provide vital oncology answers that transform the lives of people living with cancer. NeoGenomics offers a comprehensive menu of diagnostic services, ranging from traditional to state-of-the-art testing, to support a personalized test approach. The company is committed to improving patient care through communication, accuracy, reliability, and efficiency. NeoGenomics serves oncologists, pathologists, pharmaceutical companies, and academic centers in their pursuit of providing better futures for people living with cancer.